Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 40/100

Failure Rate

3.0%

1 terminated/withdrawn out of 33 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

24%

8 trials in Phase 3/4

Results Transparency

100%

1 of 1 completed trials have results

Key Signals

14 recruiting1 with results

Enrollment Performance

Analytics

Phase 4

6(27.3%)

Phase 1

5(22.7%)

Phase 2

4(18.2%)

N/A

4(18.2%)

Phase 3

2(9.1%)

Early Phase 1

1(4.5%)

22Total

Phase 4(6)

Phase 1(5)

Phase 2(4)

N/A(4)

+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (33)

Showing 20 of 33 trials

NCT07687212Phase 1Not Yet Recruiting

Randomized Double-blind Controlled Clinical Study of SGLT-2i Combined With Probiotic Preparations in Elderly Patients With HFpEF

Role: lead

NCT06538883Phase 4Completed

Sedation in ICU Patients With Mechanical Ventilation

Role: collaborator

NCT04244981Phase 4Terminated

Efficacy of Prothrombin Complex Concentrate Reducing Perioperative Blood Loss in Cardiac Surgery

Role: collaborator

NCT07096219Enrolling By Invitation

Catheter Ablation for Functional Mitral Regurgitation in Persistent Atrial Fibrillation: Development and Validation of a Predictive Model-A Multicenter Prospective Cohort Study

Role: collaborator

NCT07620626Recruiting

Real-World Study of Woven EndoBridge for Intracranial Aneurysm Treatment

Role: collaborator

NCT07632677Recruiting

Diagnostic Value of the Liver Inflammation Index for MASH in Patients With T2DM and MAFLD

Role: collaborator

NCT07628777Phase 1Not Yet Recruiting

Fecal Microbiota Transplantation for Elderly Patients With HFpEF: A Randomized Controlled Trial

Role: lead

NCT07608224Phase 2Not Yet Recruiting

HOPE-07-MIBC: Disitamab Vedotin Plus Immunotherapy vs Chemoimmunotherapy in Resectable HER2-Expressing MIBC

Role: collaborator

NCT07576517Phase 4Not Yet Recruiting

Dexmedetomidine-esketamine and tDCS for Prevention of Neurocognitive Complications After Surgery

Role: collaborator

NCT07576543Phase 4Not Yet Recruiting

Long-term Follow-up of Dexmedetomidine-esketamine and tDCS for Neurocognitive Complications After Surgery

Role: collaborator

NCT07530432Not Yet Recruiting

Analysis of Influencing Factors for the Development of PTSD in Emergency Department Trauma Patients

Role: lead

NCT06099912Recruiting

Individualized Dynamic Frailty-tailored Therapy (DynaFiT) in Elderly Patients With NDMM

Role: collaborator

NCT07266181Phase 1Recruiting

Safety and Efficacy of CD19 Chimeric Antigen Receptor T-Cell (CAR-T) in the Treatment of Refractory Membranous Nephropathy

Role: lead

NCT07240987Phase 1Not Yet Recruiting

Mesenchymal Stem Cells for Chronic Kidney Diseases

Role: lead

NCT07288749Phase 3Not Yet Recruiting

Efficacy Evaluation of Glimepiride in Patients With Type 2 Diabetes Mellitus and Chronic Heart Failure With Reduced Ejection Fraction.

Role: collaborator

NCT07267117Recruiting

Cohort Observing Mechanisms, Progression and Sequelae of Valvular Heart Disease

Role: collaborator

NCT06716658Phase 2Recruiting

JAK1 Inhibitor Golidocitnib for the Treatment of Relapsed/Refractory Indolent T/NK-cell Lymphomas

Role: collaborator

NCT07198659Early Phase 1Recruiting

A Single-Arm Investigator-Initiated Tria (IIT) Evaluating the Safety and Preliminary Efficacy of Autologous Drug-Loaded Neutrophils (NeuMed) in Patients With Unresectable Pancreatic Cancer

Role: lead

NCT06482749Not ApplicableRecruiting

Repetitive Transcranial Magnetic Stimulation and Postoperative Neurocognitive Recovery

Role: collaborator

NCT06743867Phase 1Recruiting

The Safety and Efficacy of Pressurized Intraperitoneal Aerosol Chemotherapy for Peritoneal Metastatic Adenocarcinoma

Role: collaborator